RxDoctor Payments Data

Kristi Kimbler, NP

Acute Care · Newnan, GANPI 1164081303

Payments from drug & device makers

$1,305in general payments, 2019–2025

Across 71 payments — averaging $18.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$378
  • Travere Therapeutics, Inc.$155
  • Mallinckrodt Hospital Products Inc.$139
  • Aurinia Pharma U.S., Inc.$75
  • Bayer$71
  • Novartis$69
  • plus $418 from 10 others

What the payments were for

  • Food & beverage$1,06181%
  • Education$24419%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,305 in reported general payments places this provider in the 75th percentile of 679 acute care providers in Georgia.

See all acute care providers in Georgia

Medicare billing

Part B allowed, 2024
$1,538
Medicare patients
13
Services billed
26

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol197$160,549
JardianceEmpagliflozin69$55,630
LokelmaSodium Zirconium Cyclosilicate41$31,490
Calcitriol1,434$24,432
VeltassaPatiromer Calcium Sorbitex15$22,368
EntrestoSacubitril/Valsartan16$14,758
Potassium Citrate ErPotassium Citrate155$14,079
Sevelamer Carbonate64$9,954
Calcium Acetate91$6,538
Hydralazine Hcl427$6,116
Cinacalcet Hcl41$5,890
Potassium Chloride118$2,746
Losartan Potassium324$2,479
Midodrine Hcl45$2,346
Clonidine16$2,187

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Lokelma$378$192,038238 claims
Boehringer IngelheimJardiance$47$55,63069 claims
NovartisEntresto$69$14,75816 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 679 acute care providers in Georgia.

Other acute care in Newnan

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →